OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia
Kazuomi Kario, Masafumi Nishizawa, Mari Kiuchi, et al.
Journal of Clinical Hypertension (2021) Vol. 23, Iss. 2, pp. 334-344
Open Access | Times Cited: 33
Kazuomi Kario, Masafumi Nishizawa, Mari Kiuchi, et al.
Journal of Clinical Hypertension (2021) Vol. 23, Iss. 2, pp. 334-344
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk
Claudio Borghi, Davide Agnoletti, Arrigo F.G. Cicero, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1927-1936
Open Access | Times Cited: 100
Claudio Borghi, Davide Agnoletti, Arrigo F.G. Cicero, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1927-1936
Open Access | Times Cited: 100
Hyperuricemia research progress in model construction and traditional Chinese medicine interventions
Hongyan Zhou, Jingyi Yang, Xiao Yuan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 18
Hongyan Zhou, Jingyi Yang, Xiao Yuan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 18
Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease
Hitoshi Nishizawa, Norikazu Maeda, Iichiro Shimomura
Hypertension Research (2022) Vol. 45, Iss. 4, pp. 635-640
Closed Access | Times Cited: 62
Hitoshi Nishizawa, Norikazu Maeda, Iichiro Shimomura
Hypertension Research (2022) Vol. 45, Iss. 4, pp. 635-640
Closed Access | Times Cited: 62
Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases
Masanari Kuwabara, Tomoko Fukuuchi, Yuhei Aoki, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1519-1519
Open Access | Times Cited: 34
Masanari Kuwabara, Tomoko Fukuuchi, Yuhei Aoki, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1519-1519
Open Access | Times Cited: 34
Impact of Hyper- and Hypo-Uricemia on Kidney Function
Junichiro Miake, Ichiro Hisatome, Katsuyuki Tomita, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1258-1258
Open Access | Times Cited: 25
Junichiro Miake, Ichiro Hisatome, Katsuyuki Tomita, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1258-1258
Open Access | Times Cited: 25
Review of Urate-Lowering Therapeutics: From the Past to the Future
Christopher Jenkins, Jennifer H. Hwang, Jeffrey B. Kopp, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Christopher Jenkins, Jennifer H. Hwang, Jeffrey B. Kopp, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 450-450
Open Access | Times Cited: 7
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 450-450
Open Access | Times Cited: 7
Differential effect of a xanthine oxidase inhibitor on arterial stiffness and carotid atherosclerosis: a subanalysis of the PRIZE study
Kazuki Shiina, Hirofumi Tomiyama, Atsushi Tanaka, et al.
Hypertension Research (2022) Vol. 45, Iss. 4, pp. 602-611
Closed Access | Times Cited: 20
Kazuki Shiina, Hirofumi Tomiyama, Atsushi Tanaka, et al.
Hypertension Research (2022) Vol. 45, Iss. 4, pp. 602-611
Closed Access | Times Cited: 20
Comparison of the incidence of proteinuria and changes in eGFR among febuxostat and topiroxostat users
S Nakayama, Michihiro Satoh, Maya Toyama, et al.
Clinical and Experimental Nephrology (2025)
Open Access
S Nakayama, Michihiro Satoh, Maya Toyama, et al.
Clinical and Experimental Nephrology (2025)
Open Access
Association between serum uric acid levels and arterial stiffness in patients with psoriasis
Zongyang Li, Zheng Gu, Jinfeng Xiang, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Zongyang Li, Zheng Gu, Jinfeng Xiang, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Cardiovascular Events During Treatment With Xanthine Oxidoreductase Inhibitors in Patients With Gout and Hyperuricemia in Japan ― A JMDC Claims Database Study ―
Kazuomi Kario, Seigo Akari, Hiroshi Kanegae
Circulation Reports (2025) Vol. 7, Iss. 3, pp. 183-190
Open Access
Kazuomi Kario, Seigo Akari, Hiroshi Kanegae
Circulation Reports (2025) Vol. 7, Iss. 3, pp. 183-190
Open Access
The crystal structure of topiroxostat, C13H8N6
Fengfeng Wang, Caiyu Zhang, Lin Luan, et al.
Zeitschrift für Kristallographie - New Crystal Structures (2025)
Open Access
Fengfeng Wang, Caiyu Zhang, Lin Luan, et al.
Zeitschrift für Kristallographie - New Crystal Structures (2025)
Open Access
Uric acid, xanthine oxidase, and vascular damage: potential of xanthine oxidoreductase inhibitors to prevent cardiovascular diseases
Hiromitsu Sekizuka
Hypertension Research (2022) Vol. 45, Iss. 5, pp. 772-774
Open Access | Times Cited: 16
Hiromitsu Sekizuka
Hypertension Research (2022) Vol. 45, Iss. 5, pp. 772-774
Open Access | Times Cited: 16
Cardiovascular significance of adipose-derived adiponectin and liver-derived xanthine oxidoreductase in metabolic syndrome
Yuya Fujishima, Shunbun Kita, Hitoshi Nishizawa, et al.
Endocrine Journal (2023) Vol. 70, Iss. 7, pp. 663-675
Open Access | Times Cited: 9
Yuya Fujishima, Shunbun Kita, Hitoshi Nishizawa, et al.
Endocrine Journal (2023) Vol. 70, Iss. 7, pp. 663-675
Open Access | Times Cited: 9
Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation
Yusuke Kawachi, Yuya Fujishima, Hitoshi Nishizawa, et al.
JCI Insight (2021) Vol. 6, Iss. 17
Open Access | Times Cited: 20
Yusuke Kawachi, Yuya Fujishima, Hitoshi Nishizawa, et al.
JCI Insight (2021) Vol. 6, Iss. 17
Open Access | Times Cited: 20
Febuxostat and renal outcomes: post-hoc analysis of a randomized trial
Kentaro Kohagura, Sunao Kojima, Kazuaki Uchiyama, et al.
Hypertension Research (2023) Vol. 46, Iss. 6, pp. 1417-1422
Closed Access | Times Cited: 6
Kentaro Kohagura, Sunao Kojima, Kazuaki Uchiyama, et al.
Hypertension Research (2023) Vol. 46, Iss. 6, pp. 1417-1422
Closed Access | Times Cited: 6
Independent association of plasma xanthine oxidoreductase activity with hypertension in nondiabetic subjects not using medication
Masato Furuhashi, Yukimura Higashiura, Masayuki Koyama, et al.
Hypertension Research (2021) Vol. 44, Iss. 9, pp. 1213-1220
Closed Access | Times Cited: 14
Masato Furuhashi, Yukimura Higashiura, Masayuki Koyama, et al.
Hypertension Research (2021) Vol. 44, Iss. 9, pp. 1213-1220
Closed Access | Times Cited: 14
The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study
Yuya Fujishima, Hitoshi Nishizawa, Yusuke Kawachi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 674-674
Open Access | Times Cited: 5
Yuya Fujishima, Hitoshi Nishizawa, Yusuke Kawachi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 674-674
Open Access | Times Cited: 5
The reality of treatment for hyperuricemia and gout in Japan: A historical cohort study using health insurance claims data
Seigo Akari, Takashi Nakamura, Kenichi Furusawa, et al.
Journal of Clinical Hypertension (2022) Vol. 24, Iss. 8, pp. 1068-1075
Open Access | Times Cited: 7
Seigo Akari, Takashi Nakamura, Kenichi Furusawa, et al.
Journal of Clinical Hypertension (2022) Vol. 24, Iss. 8, pp. 1068-1075
Open Access | Times Cited: 7
Association of serum uric acid with the risk of developing hypertension: A prospective cohort study with mediation analysis
Jing Dong, Li‐Kun Hu, Ya‐Ke Lu, et al.
Hypertension Research (2022) Vol. 46, Iss. 2, pp. 345-356
Closed Access | Times Cited: 7
Jing Dong, Li‐Kun Hu, Ya‐Ke Lu, et al.
Hypertension Research (2022) Vol. 46, Iss. 2, pp. 345-356
Closed Access | Times Cited: 7
Relationship of Serum Uric Acid with Kidney Function Decline Mediated by Systemic Arterial Stiffness: A Retrospective Cohort Study in Japan
Daiji Nagayama, Yasuhiro Watanabe, Kentaro Fujishiro, et al.
Diagnostics (2024) Vol. 14, Iss. 2, pp. 195-195
Open Access | Times Cited: 1
Daiji Nagayama, Yasuhiro Watanabe, Kentaro Fujishiro, et al.
Diagnostics (2024) Vol. 14, Iss. 2, pp. 195-195
Open Access | Times Cited: 1
Effect of the Xanthine Oxidase Inhibitor Febuxostat on the Cardio-Ankle Vascular Index in Asymptomatic Patients with Hyperuricemia and Liver Dysfunction: A Sub-Analysis of the PRIZE Study
Yusuke Kawachi, Yuya Fujishima, Hitoshi Nishizawa, et al.
Journal of Atherosclerosis and Thrombosis (2024)
Open Access | Times Cited: 1
Yusuke Kawachi, Yuya Fujishima, Hitoshi Nishizawa, et al.
Journal of Atherosclerosis and Thrombosis (2024)
Open Access | Times Cited: 1
Effect of Topiroxostat on Reducing Oxidative Stress in the Aorta of Streptozotocin-Induced Diabetic Rats
Masato Noda, Chigusa Kikuchi, Ryota Tarui, et al.
Biological and Pharmaceutical Bulletin (2022) Vol. 46, Iss. 2, pp. 272-278
Open Access | Times Cited: 4
Masato Noda, Chigusa Kikuchi, Ryota Tarui, et al.
Biological and Pharmaceutical Bulletin (2022) Vol. 46, Iss. 2, pp. 272-278
Open Access | Times Cited: 4
A Possible Therapeutic Application of The Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease: A Significance of Inhibition of Urate Transporter 1 and Non-inhibition of Other Urate Transporters for Such Diseases
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
(2023)
Open Access | Times Cited: 1
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
(2023)
Open Access | Times Cited: 1
Navigating the choice between topiroxostat and febuxostat for hyperuricemia management: A prospective comparative study
Rithvic Kevin P, Vishnu Senthil, Manish Khanna
International Journal of Orthopaedics Sciences (2024) Vol. 10, Iss. 2, pp. 04-10
Open Access
Rithvic Kevin P, Vishnu Senthil, Manish Khanna
International Journal of Orthopaedics Sciences (2024) Vol. 10, Iss. 2, pp. 04-10
Open Access
